Clinical trial
Vancomycin Exposure, Nephrotoxicity, and Sepsis Biomarker Tracking Using Real-time Monitoring of Interstitial Fluid
NCT07893223 is registered in ClinicalTrials.gov with Nutromics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Vancomycin Exposure, Nephrotoxicity, and Sepsis Biomarker Tracking Using Real-time Monitoring of Interstitial Fluid
- Lead sponsor
- Nutromics
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- December 31, 2026
- Completion date
- December 31, 2028
- Enrollment
- 200 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
acute kidney injury, biomarkers, sepsis
Arms
As registered; 2 arms.
-
Cohort 1
Hospitalised participants receiving vancomycin (Vancomycin monitoring)
-
Cohort 2
Hospitalised participants not receiving vancomycin (Biomarker Monitoring)
Primary endpoints
Registered primary outcome measures; 4 primary.
-
Accuracy of Device-measured vancomycin ISF concentration vs. paired serum concentration
Comparison of vancomycin concentration-time profiles and pharmacokinetic parameters (Cmax, Tmax, Cmin, AUC0-24) derived from interstitial fluid (Sensor Device) against paired serum vancomycin immunoassay results.
-
Accuracy of Device-measured biomarker (creatinine, C-reactive protein, lactate) ISF concentration vs. paired serum concentration
Determination of accuracy between Device-reported biomarker values and paired serum immunoassay results.
-
Relationship between ISF analyte concentrations and clinical outcomes
Descriptive summary of association between ISF concentration profiles (vancomycin, creatinine, C-reactive protein, lactate) and 30-day clinical outcomes (discharge/readmission, morbidity, mortality, treatment-emergent adverse events).
-
General performance characterisation of the Device
Paired precision between simultaneously worn devices; device accuracy throughout wear duration; electrochemical sensor quality metrics.
Similar trials
Same condition (Acute Kidney Injury) and phase, most recent start first.
+792 more trials See the condition page